| Chlorocebus sabaeus |
Vero |
IC50 |
119000.0 |
nM |
10.1016/j.ejmech.2015.05.020 |
| Chlorocebus sabaeus |
Vero |
IC50 |
119000.0 |
nM |
10.1039/C3MD00097D |
| Homo sapiens |
AMP-activated protein kinase, AMPK |
Inhibition |
0.0 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
BT-549 |
IC50 |
nan |
None |
10.1016/j.ejmech.2015.05.020 |
| Homo sapiens |
cAMP-dependent protein kinase (PKA) |
IC50 |
120000.0 |
nM |
10.1016/j.bmcl.2004.01.050 |
| Homo sapiens |
Casein kinase I |
IC50 |
nan |
nM |
10.1016/j.bmcl.2004.01.050 |
| Homo sapiens |
Casein kinase I alpha |
Inhibition |
0.0 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
CDK2/Cyclin A2 |
Inhibition |
54.0 |
% |
10.1016/j.bmcl.2014.04.035 |
| Homo sapiens |
Cyclin-dependent kinase 1/cyclin B |
IC50 |
150000.0 |
nM |
10.1016/j.bmcl.2004.01.050 |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Inhibition |
0.0 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
Cyclin-dependent kinase 5/CDK5 activator 1 |
IC50 |
5000.0 |
nM |
10.1021/jm200464w |
| Homo sapiens |
Cyclin-dependent kinase 5/CDK5 activator 1 |
IC50 |
140000.0 |
nM |
10.1016/j.bmcl.2004.01.050 |
| Homo sapiens |
Cyclin-dependent kinase 9 |
Inhibition |
3.8 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
DU-145 |
IC50 |
nan |
None |
10.1021/jm200464w |
| Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A |
IC50 |
588.0 |
nM |
10.1016/j.bmcl.2017.03.037 |
| Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A |
Inhibition |
29.8 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
Dual specificty protein kinase CLK1 |
IC50 |
530.0 |
nM |
10.1021/jm200464w |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
IC50 |
14810.0 |
nM |
10.1016/j.bmcl.2017.03.037 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
IC50 |
350000.0 |
nM |
10.1016/j.bmcl.2004.01.050 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
IC50 |
350000.0 |
nM |
10.1016/j.ejmech.2008.08.012 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Inhibition |
0.0 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
HepG2 |
Activity |
nan |
None |
10.1016/j.bmc.2006.11.023 |
| Homo sapiens |
HepG2 |
IC50 |
119000.0 |
nM |
10.1039/C3MD00097D |
| Homo sapiens |
IMR-32 |
IC50 |
25000.0 |
nM |
10.1021/jm200464w |
| Homo sapiens |
Inhibitor of nuclear factor kappa B kinase beta subunit |
Inhibition |
16.6 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
Insulin-like growth factor I receptor |
Inhibition |
0.0 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
Insulin receptor |
Inhibition |
9.6 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
KB |
IC50 |
nan |
None |
10.1016/j.ejmech.2015.05.020 |
| Homo sapiens |
MCF7 |
IC50 |
25000.0 |
nM |
10.1021/jm200464w |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 14 |
IC50 |
41000.0 |
nM |
10.1016/j.bmcl.2013.01.012 |
| Homo sapiens |
Nuclear factor of activated T-cells cytoplasmic 1 |
EC50 |
nan |
None |
10.1016/j.bmcl.2017.03.037 |
| Homo sapiens |
PA-1 |
IC50 |
nan |
None |
10.1021/jm200464w |
| Homo sapiens |
PC-3 |
IC50 |
nan |
None |
10.1021/jm200464w |
| Homo sapiens |
Protein kinase C alpha |
Inhibition |
8.5 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
Serine/threonine-protein kinase AKT |
Inhibition |
22.3 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
Serine/threonine-protein kinase AKT2 |
Inhibition |
0.0 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Inhibition |
5.1 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-B |
Inhibition |
4.1 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
SH-SY5Y |
Activity |
91.4 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
SH-SY5Y |
IC50 |
25000.0 |
nM |
10.1021/jm200464w |
| Homo sapiens |
SK-MEL |
IC50 |
nan |
None |
10.1016/j.ejmech.2015.05.020 |
| Homo sapiens |
SK-OV-3 |
IC50 |
nan |
None |
10.1016/j.ejmech.2015.05.020 |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Inhibition |
7.1 |
% |
10.1016/j.bmcl.2015.05.034 |
| Homo sapiens |
U-251 |
Activity |
nan |
None |
10.1016/j.bmc.2006.11.023 |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Inhibition |
8.0 |
% |
10.1016/j.bmcl.2015.05.034 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1039/C3MD00097D |
| Leishmania donovani |
Leishmania donovani |
IC90 |
nan |
None |
10.1039/C3MD00097D |
| Mus musculus |
Ehrlich |
Activity |
nan |
None |
10.1016/j.bmc.2006.11.023 |
| Mus musculus |
HT-22 |
IC50 |
25000.0 |
nM |
10.1021/jm200464w |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
304800.0 |
nM |
10.1016/j.ejmech.2015.05.020 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
EC50 |
50000.0 |
nM |
10.1039/c9md00466a |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
IC50 |
29500.0 |
nM |
10.1039/c9md00466a |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
4436.09 |
nM |
10.1016/j.ejmech.2015.05.020 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
4440.0 |
nM |
10.1016/j.ejmech.2015.05.020 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
4440.0 |
nM |
10.1039/C3MD00097D |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
9682.78 |
nM |
10.1016/j.ejmech.2015.05.020 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
9690.0 |
nM |
10.1016/j.ejmech.2015.05.020 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
9690.0 |
nM |
10.1039/C3MD00097D |
| Rattus norvegicus |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A |
IC50 |
700.0 |
nM |
10.1021/jm200464w |
| Sus scrofa |
Glycogen synthase kinase-3 |
IC50 |
10000.0 |
nM |
10.1021/jm200464w |
| Sus scrofa |
LLC-PK1 |
IC50 |
107000.0 |
nM |
10.1016/j.ejmech.2015.05.020 |
| Sus scrofa |
LLC-PK1 |
IC50 |
107000.0 |
nM |
10.1039/C3MD00097D |
| None |
ADMET |
IC50 |
nan |
None |
10.1021/jm200464w |
| None |
No relevant target |
LogD7.4 |
1.68 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Solubility |
575400.0 |
nM |
10.6019/CHEMBL3301361 |
| None |
Unchecked |
IC50 |
6200.0 |
nM |
10.1021/jm200464w |
| None |
Unchecked |
IC50 |
400000.0 |
nM |
10.1016/j.bmcl.2004.01.050 |
| None |
Unchecked |
Ratio IC50 |
11.1 |
None |
10.1016/j.ejmech.2015.05.020 |
| None |
Unchecked |
Ratio IC50 |
11.1 |
None |
10.1039/C3MD00097D |
| None |
Unchecked |
Ratio IC50 |
12.3 |
None |
10.1016/j.ejmech.2015.05.020 |
| None |
Unchecked |
Ratio IC50 |
12.3 |
None |
10.1039/C3MD00097D |
| None |
Unchecked |
Ratio IC50 |
24.1 |
None |
10.1016/j.ejmech.2015.05.020 |
| None |
Unchecked |
Ratio IC50 |
24.1 |
None |
10.1039/C3MD00097D |
| None |
Unchecked |
Ratio IC50 |
26.8 |
None |
10.1016/j.ejmech.2015.05.020 |
| None |
Unchecked |
Ratio IC50 |
26.8 |
None |
10.1039/C3MD00097D |